Skip to main content
Log in

Akute Lungenembolie und Kontraindikation für eine Antikoagulation

Bettseitige Implantation eines neuen passageren V.-cava-inferior-Filters

Acute pulmonary embolism and contraindication of anticoagulation

Bedside implantation of a new temporary vena cava inferior filter

  • Kasuistiken
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

Zusammenfassung

Lungenarterienembolien (LE) sind lebensgefährliche Komplikationen, häufig bedingt durch tiefe Beinvenenthrombosen bei kritisch kranken Patienten auf Intensivstationen. Bei Vorliegen von Kontraindikationen gegenüber einer Antikoagulation stellt die Implantation eines V.-cava-Filters (VCF) eine mögliche Alternative zur Prophylaxe einer LE dar. Sie kann Schutz vor aszendierenden Thromben bieten. Wir berichten über den Fall einer 56-jährigen Patientin mit intrazerebraler Blutung, die eine 2‑malige zentrale LE erlitt. Bei Kontraindikation einer aktuellen Antikoagulation erfolgte die bettseitige Implantation eines neuartigen VCF bis zur Überbrückung der Kontraindikationsphase für Antikoagulation. Bei Entfernung konnten mehrere Thromben im Nitinolgerüst des VCF nachgewiesen werden.

Abstract

Pulmonary embolism (PE), mostly caused by deep vein thrombosis, is a life-threatening complication in critically ill patients in the intensive care unit. A potential strategy to prevent PE in patients with contraindication for anticoagulant therapy is the implantation of a vena cava filter (VCF), to provide fast and safe PE protection against ascending thrombi. We report the case of a 56-year-old woman with an intracranial hemorrhage, who developed a PE. Because of acute contraindications for anticoagulant therapy, bedside implantation of a new VCF was performed to overcome the period of absolute contraindications for anticoagulation. After explanation, several thrombi were found on the filter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Petros S (2016) Thromboprophylaxis in the critically ill: Low molecular weight heparin versus unfractionated heparin. Medizinische Klin Intensivmed Notfallmed 111(1):55–56

    Article  CAS  Google Scholar 

  2. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161(10):1268–1279

    Article  CAS  PubMed  Google Scholar 

  3. Group PIftCCCT, the A, New Zealand Intensive Care Society Clinical Trials G, Cook D, Meade M, Guyatt G et al (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364(14):1305–1314

    Article  CAS  PubMed  Google Scholar 

  4. Bahloul M, Chaari A, Kallel H, Abid L, Hamida CB, Dammak H et al (2010) Pulmonary embolism in intensive care unit: predictive factors, clinical manifestations and outcome. Ann Thorac Med 5(2):97–103

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371(9610):387–394

    Article  PubMed  Google Scholar 

  6. Goldhaber SZ, Tapson VF, Committee DFS (2004) A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 93(2):259–262

    Article  PubMed  Google Scholar 

  7. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N et al (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–3069 (69a–69k)

    Article  CAS  PubMed  Google Scholar 

  8. Greenfield LJ, McCurdy JR, Brown PP, Elkins RC (1973) A new intracaval filter permitting continued flow and resolution of emboli. Surgery 73(4):599–606

    CAS  PubMed  Google Scholar 

  9. Cadavid CA, Gil B, Restrepo A, Alvarez S, Echeverry S, Angel LF et al (2013) Pilot study evaluating the safety of a combined central venous catheter and inferior vena cava filter in critically ill patients at high risk of pulmonary embolism. J Vasc Interv Radiol 24(4):581–585

    Article  PubMed  Google Scholar 

  10. Becker DM, Philbrick JT, Selby JB (1992) Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 152(10):1985–1994

    Article  CAS  PubMed  Google Scholar 

  11. Caplin DM, Nikolic B, Kalva SP, Ganguli S, Saad WE, Zuckerman DA et al (2011) Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 22(11):1499–1506

    PubMed  Google Scholar 

  12. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338(7):409–415

    Article  CAS  PubMed  Google Scholar 

  13. Mismetti P, Laporte S, Pellerin O, Ennezat PV, Couturaud F, Elias A et al (2015) Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 313(16):1627–1635

    Article  PubMed  Google Scholar 

  14. White RH, Brunson A, Romano PS, Li Z, Wun T (2016) Outcomes after vena cava filter use in noncancer patients with acute venous thromboembolism: a population-based study. Circulation 133(21):2018–2029

    Article  CAS  PubMed  Google Scholar 

  15. Goldhaber SZ (2016) Requiem for liberalizing indications for vena caval filters? Circulation 133(21):1992–1994

    Article  PubMed  Google Scholar 

  16. Taccone FS, Bunker N, Waldmann C, De Backer D, Brohi K, Jones RG et al (2015) A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry. J Trauma Acute Care Surg 79(3):456–462

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Baumann.

Ethics declarations

Interessenkonflikt

S. Baumann, T. Becher, C. Jabbour, C. Fastner, K. Giannakopoulos, M. Behnes, T. Henzler, A. Alonso, S. Britsch, D. Loßnitzer, M. Borggrefe und I. Akin geben an, den bettseitig implantierbaren V.-cava-Filter (Angel® Catheter) kostenfrei von der Firma BiO2 Medical, Inc. (San Antonio, TX, USA) zur Verfügung gestellt bekommen zu haben, jedoch keine Honorare oder sonstige finanzielle Zuwendungen erhalten zu haben.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Alle Patienten, die über Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.

Additional information

Redaktion

R. Riessen, Tübingen

Die Autoren S. Baumann und T. Becher haben zu gleichen Teilen zu diesem Manuskript beigetragen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baumann, S., Becher, T., Jabbour, C. et al. Akute Lungenembolie und Kontraindikation für eine Antikoagulation. Med Klin Intensivmed Notfmed 112, 246–251 (2017). https://doi.org/10.1007/s00063-016-0201-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-016-0201-9

Schlüsselwörter

Keywords

Navigation